Home › Stocks › IMMX › All Fund Holders
IMMX — IMMIX BIOPHARMA INC · All Fund Holders
Funds holding (latest): 29 · Reported value held: $210.31M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Janus Henderson Group history | Q1 2026 | 4.80M | $43.70M | 0.02% | Add |
| BlackRock Inc history | Q2 2026 | 2.99M | $30.83M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 2.07M | $21.30M | 0.01% | Add |
| UBS Group AG history | Q2 2026 | 1.94M | $20.02M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 1.79M | $18.51M | 0.01% | Add |
| Wellington Management Group history | Q2 2026 | 1.47M | $15.19M | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 1.20M | $12.39M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 969.12K | $9.99M | 0.00% | Hold |
| Vanguard Group history | Q4 2025 | 1.10M | $5.73M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 537.76K | $5.54M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 418.05K | $4.31M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 417.23K | $4.30M | 0.01% | New |
| Bank of America Corp history | Q2 2026 | 413.14K | $4.26M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 235.72K | $2.43M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 174.11K | $1.80M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 159.47K | $1.64M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 146.85K | $1.51M | 0.00% | Add |
| Renaissance Technologies history | Q4 2025 | 258.60K | $1.35M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 127.26K | $1.31M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 113.32K | $1.17M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 93.11K | $959.92K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 70.65K | $728.44K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 40.86K | $421.28K | 0.00% | New |
| Two Sigma Investments history | Q2 2026 | 40.18K | $414.27K | 0.00% | New |
| Invesco Ltd history | Q2 2026 | 22.32K | $230.10K | 0.00% | New |
| JPMorgan Chase & Co history | Q2 2026 | 19.57K | $205.34K | 0.00% | New |
| Legal & General Investment Management America history | Q2 2026 | 3.98K | $41.09K | 0.00% | New |
| T. Rowe Price Associates history | Q2 2026 | 1.74M | $17.94K | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 61 | $629 | 0.00% | New |